![Chronic Alcohol Use : Genetic Variations Provide Protection from Liver Cancer | Université Paris Cité Chronic Alcohol Use : Genetic Variations Provide Protection from Liver Cancer | Université Paris Cité](https://u-paris.fr/wp-content/uploads/2021/12/Foie-1920X1080.jpeg)
Chronic Alcohol Use : Genetic Variations Provide Protection from Liver Cancer | Université Paris Cité
![Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth - ScienceDirect Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827822001301-ga1.jpg)
Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth - ScienceDirect
![Cancers | Free Full-Text | The lncRNA H19-Derived MicroRNA-675 Promotes Liver Necroptosis by Targeting FADD Cancers | Free Full-Text | The lncRNA H19-Derived MicroRNA-675 Promotes Liver Necroptosis by Targeting FADD](https://www.mdpi.com/cancers/cancers-13-00411/article_deploy/html/images/cancers-13-00411-g001.png)
Cancers | Free Full-Text | The lncRNA H19-Derived MicroRNA-675 Promotes Liver Necroptosis by Targeting FADD
![Frontiers | The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective Frontiers | The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective](https://www.frontiersin.org/files/Articles/888850/fmed-09-888850-HTML/image_m/fmed-09-888850-g001.jpg)
Frontiers | The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective
BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA
![The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma | Request PDF The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma | Request PDF](https://i1.rgstatic.net/publication/345674594_The_pro-oncogenic_effect_of_the_lncRNA_H19_in_the_development_of_chronic_inflammation-mediated_hepatocellular_carcinoma/links/5fb27dce299bf10c3683e6d3/largepreview.png)
The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma | Request PDF
![Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response - ScienceDirect Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S001650851936771X-fx1.jpg)
Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response - ScienceDirect
![Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial - UROONCO Kidney Cancer Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial - UROONCO Kidney Cancer](https://kidney.uroonco.uroweb.org/wp-content/uploads/sites/8/RCC-logo-default-fb.png)
Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial - UROONCO Kidney Cancer
![Deleting in vivo β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumors | bioRxiv Deleting in vivo β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumors | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/07/05/2021.07.04.450836/F1.large.jpg)